Welsis CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Welsis Corp. reported a significant increase in net loss to $60,690 for fiscal year 2025, transitioning from teletherapy to a cryptocurrency exchange business while facing substantial doubt about its ability to continue as a going concern.
OTC.Pink
Welsis Corp.'s latest 10-K filing reveals a net loss, but also highlights a decrease in the loss compared to the previous year, alongside a strategic shift into the cryptocurrency sector.